Biotech company NeoTXis' Tumor Targeted Superantigen (TTS) technology works to kill cancer cells in a way that no other available cancer treatment can.
/PRNewswire/ NeoTX Therapeutics (NeoTX), a clinical-stage immuno-oncology company, announced the promotion of current CMO, Marcel Rozencweig, M.D., to.